Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Female scientist sitting in a lab using equipment

CELT Global Health

Our mission, as an internationally recognised Centre of Excellence, is to drive awareness, understanding, development, and equitable implementation of long-acting therapeutics for unmet global health needs.

1st
research centre of its kind in the world with scientists from pharmacology and materials chemistry working together.
£80m
ongoing research funding dedicated to our diverse project portfolio.
50+
staff members committed to long-acting therapeutics research.
Watch on YouTube:

Broadening our understanding of long-acting medicines

Find out more about us with CELT Global Health Co-director, Professor Andrew Owen as he introduces the Centre of Excellence for Long-acting Therapeutics at the University of Liverpool.

A scientist is using a weighing balance on their workbench.

About us

Learn about CELT Global Health's long acting-therapeutics work, our team, partners and how to work with us.

A scientist is working in their lab

Our research

Find out about our different active and finished long-acting therapeutics research projects and our publications.

A person is reading the news on their tablet

Global Long-acting therapeutics news stories

CELT Global Health are not the only team working in long-acting therapeutics. Find global news from industry you may have missed.

A crowded audience clapping at a conference event

Events and conferences

Discover where CELT Global Health will be presenting our work, and other events CELT Global Health are happy to endorse.

a woman stares into the distance in front of a beautiful rural landscape with an orange sunrise.

The LONGEVITY Project

The LONGEVITY Project is an international consortium, developing long-acting medicines intended for the prevention of malaria and tuberculosis, as well as a single-injection cure for the hepatitis C virus. With our combined expertise, new medicines we create will be deployed in low- and middle-income countries where the burden is highest.

Funder

The Centre of Excellence for Long-acting Therapeutics, which became CELT Global Health in 2025, was established with funding from Unitaid.

News

Read more news

Follow our twitter feed